Swiss Life Asset Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-22,192
Closed -$4.71M 662
2023
Q3
$4.71M Sell
22,192
-15,702
-41% -$3.14M 0.07% 306
2023
Q2
$7.29M Sell
37,894
-4,925
-12% -$978K 0.11% 234
2023
Q1
$8.67M Buy
42,819
+37,207
+663% +$5.97M 0.13% 200
2022
Q4
$722K Sell
5,612
-1,869
-25% -$241K 0.01% 519
2022
Q3
$1.02M Sell
7,481
-227
-3% -$37K 0.02% 482
2022
Q2
$1.36M Buy
+7,708
New +$1.11M 0.02% 465
2021
Q3
Sell
-21,039
Closed -$1.16M 580
2021
Q2
$1.16M Buy
+21,039
New +$3.13M 0.01% 461
2018
Q4
Sell
-2,772
Closed -$214K 489
2018
Q3
$214K Buy
+2,772
New +$204K ﹤0.01% 526

Other funds holding SGEN

Swiss Life Asset Management's SGEN Position: Q4 2023 in Review

Swiss Life Asset Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 22,192 shares — an estimated $4.71M sold.

Swiss Life Asset Management first reported a position in SGEN in Q3 2018 and held it in 8 quarters. The position peaked at $8.67M in Q1 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Swiss Life Asset Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Swiss Life Asset Management sold 22,192 Seagen Inc. Common Stock shares in Q4 2023, an estimated $4.71M.
  • Swiss Life Asset Management first reported a position in Seagen Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • Swiss Life Asset Management's Seagen Inc. Common Stock position peaked at $8.67M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Swiss Life Asset Management's 13F filing for Q4 2023, filed 9 Dec 2025.